Cargando…
Characteristics of Viral Shedding Time in SARS-CoV-2 Infections: A Systematic Review and Meta-Analysis
Background: The viral shedding time (VST) of SARS-CoV-2 mainly determines its transmission and duration of infectiousness. However, it was heterogeneous in the existing studies. Here, we performed a meta-analysis to comprehensively summarize the VST of SARS-CoV-2. Methods: We searched PubMed, Web of...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017277/ https://www.ncbi.nlm.nih.gov/pubmed/33816427 http://dx.doi.org/10.3389/fpubh.2021.652842 |
_version_ | 1783674030936555520 |
---|---|
author | Yan, Danying Zhang, Xiaobao Chen, Can Jiang, Daixi Liu, Xiaoxiao Zhou, Yuqing Huang, Chenyang Zhou, Yiyi Guan, Zhou Ding, Cheng Chen, Lu Lan, Lei Fu, Xiaofang Wu, Jie Li, Lanjuan Yang, Shigui |
author_facet | Yan, Danying Zhang, Xiaobao Chen, Can Jiang, Daixi Liu, Xiaoxiao Zhou, Yuqing Huang, Chenyang Zhou, Yiyi Guan, Zhou Ding, Cheng Chen, Lu Lan, Lei Fu, Xiaofang Wu, Jie Li, Lanjuan Yang, Shigui |
author_sort | Yan, Danying |
collection | PubMed |
description | Background: The viral shedding time (VST) of SARS-CoV-2 mainly determines its transmission and duration of infectiousness. However, it was heterogeneous in the existing studies. Here, we performed a meta-analysis to comprehensively summarize the VST of SARS-CoV-2. Methods: We searched PubMed, Web of Science, MedRxiv, BioRxiv, CNKI, CSTJ, and Wanfang up to October 25, 2020, for studies that reported VSTs of SARS-CoV-2. Pooled estimates and 95% CIs for the VSTs were calculated using log-transformed data. The VSTs in SARS-CoV-2 infections based on different demographic and clinical characteristics, treatments and specimens were stratified by subgroup analysis. Results: A total of 35 studies involving 3,385 participants met the inclusion criteria. The pooled mean VST was 16.8 days (95% CI: 14.8–19.4, I(2) = 99.56%) in SARS-CoV-2 infections. The VST was significantly longer in symptomatic infections (19.7 days, 95% CI: 17.2–22.7, I(2) = 99.34%) than in asymptomatic infections (10.9 days, 95% CI: 8.3–14.3, I(2) = 98.89%) (P < 0.05). The VST was 23.2 days (95% CI: 19.0–28.4, I(2) = 99.24%) in adults, which was significantly longer than that in children (9.9 days, 95% CI: 8.1–12.2, I(2) = 85.74%) (P < 0.05). The VST was significantly longer in persons with chronic diseases (24.2 days, 95% CI: 19.2–30.2, I(2) = 84.07%) than in those without chronic diseases (11.5 days, 95% CI: 5.3–25.0, I(2) = 82.11%) (P < 0.05). Persons receiving corticosteroid treatment (28.3 days, 95% CI: 25.6–31.2, I(2) = 0.00%) had a longer VST than those without corticosteroid treatment (16.2 days, 95% CI: 11.5–22.5, I(2) = 92.27%) (P = 0.06). The VST was significantly longer in stool specimens (30.3 days, 95% CI: 23.1–39.2, I(2) = 92.09%) than in respiratory tract specimens (17.5 days, 95% CI: 14.9–20.6, I(2) = 99.67%) (P < 0.05). Conclusions: A longer VST was found in symptomatic infections, infected adults, persons with chronic diseases, and stool specimens. |
format | Online Article Text |
id | pubmed-8017277 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80172772021-04-03 Characteristics of Viral Shedding Time in SARS-CoV-2 Infections: A Systematic Review and Meta-Analysis Yan, Danying Zhang, Xiaobao Chen, Can Jiang, Daixi Liu, Xiaoxiao Zhou, Yuqing Huang, Chenyang Zhou, Yiyi Guan, Zhou Ding, Cheng Chen, Lu Lan, Lei Fu, Xiaofang Wu, Jie Li, Lanjuan Yang, Shigui Front Public Health Public Health Background: The viral shedding time (VST) of SARS-CoV-2 mainly determines its transmission and duration of infectiousness. However, it was heterogeneous in the existing studies. Here, we performed a meta-analysis to comprehensively summarize the VST of SARS-CoV-2. Methods: We searched PubMed, Web of Science, MedRxiv, BioRxiv, CNKI, CSTJ, and Wanfang up to October 25, 2020, for studies that reported VSTs of SARS-CoV-2. Pooled estimates and 95% CIs for the VSTs were calculated using log-transformed data. The VSTs in SARS-CoV-2 infections based on different demographic and clinical characteristics, treatments and specimens were stratified by subgroup analysis. Results: A total of 35 studies involving 3,385 participants met the inclusion criteria. The pooled mean VST was 16.8 days (95% CI: 14.8–19.4, I(2) = 99.56%) in SARS-CoV-2 infections. The VST was significantly longer in symptomatic infections (19.7 days, 95% CI: 17.2–22.7, I(2) = 99.34%) than in asymptomatic infections (10.9 days, 95% CI: 8.3–14.3, I(2) = 98.89%) (P < 0.05). The VST was 23.2 days (95% CI: 19.0–28.4, I(2) = 99.24%) in adults, which was significantly longer than that in children (9.9 days, 95% CI: 8.1–12.2, I(2) = 85.74%) (P < 0.05). The VST was significantly longer in persons with chronic diseases (24.2 days, 95% CI: 19.2–30.2, I(2) = 84.07%) than in those without chronic diseases (11.5 days, 95% CI: 5.3–25.0, I(2) = 82.11%) (P < 0.05). Persons receiving corticosteroid treatment (28.3 days, 95% CI: 25.6–31.2, I(2) = 0.00%) had a longer VST than those without corticosteroid treatment (16.2 days, 95% CI: 11.5–22.5, I(2) = 92.27%) (P = 0.06). The VST was significantly longer in stool specimens (30.3 days, 95% CI: 23.1–39.2, I(2) = 92.09%) than in respiratory tract specimens (17.5 days, 95% CI: 14.9–20.6, I(2) = 99.67%) (P < 0.05). Conclusions: A longer VST was found in symptomatic infections, infected adults, persons with chronic diseases, and stool specimens. Frontiers Media S.A. 2021-03-19 /pmc/articles/PMC8017277/ /pubmed/33816427 http://dx.doi.org/10.3389/fpubh.2021.652842 Text en Copyright © 2021 Yan, Zhang, Chen, Jiang, Liu, Zhou, Huang, Zhou, Guan, Ding, Chen, Lan, Fu, Wu, Li and Yang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Yan, Danying Zhang, Xiaobao Chen, Can Jiang, Daixi Liu, Xiaoxiao Zhou, Yuqing Huang, Chenyang Zhou, Yiyi Guan, Zhou Ding, Cheng Chen, Lu Lan, Lei Fu, Xiaofang Wu, Jie Li, Lanjuan Yang, Shigui Characteristics of Viral Shedding Time in SARS-CoV-2 Infections: A Systematic Review and Meta-Analysis |
title | Characteristics of Viral Shedding Time in SARS-CoV-2 Infections: A Systematic Review and Meta-Analysis |
title_full | Characteristics of Viral Shedding Time in SARS-CoV-2 Infections: A Systematic Review and Meta-Analysis |
title_fullStr | Characteristics of Viral Shedding Time in SARS-CoV-2 Infections: A Systematic Review and Meta-Analysis |
title_full_unstemmed | Characteristics of Viral Shedding Time in SARS-CoV-2 Infections: A Systematic Review and Meta-Analysis |
title_short | Characteristics of Viral Shedding Time in SARS-CoV-2 Infections: A Systematic Review and Meta-Analysis |
title_sort | characteristics of viral shedding time in sars-cov-2 infections: a systematic review and meta-analysis |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017277/ https://www.ncbi.nlm.nih.gov/pubmed/33816427 http://dx.doi.org/10.3389/fpubh.2021.652842 |
work_keys_str_mv | AT yandanying characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis AT zhangxiaobao characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis AT chencan characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis AT jiangdaixi characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis AT liuxiaoxiao characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis AT zhouyuqing characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis AT huangchenyang characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis AT zhouyiyi characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis AT guanzhou characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis AT dingcheng characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis AT chenlu characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis AT lanlei characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis AT fuxiaofang characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis AT wujie characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis AT lilanjuan characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis AT yangshigui characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis |